EQ

1.0605.36%
SC

Stephen Connelly

Chief Scientific Officer & President

Dr. Stephen Connelly, Ph.D. was Director of Equillium, Inc. from January 01, 2018 to October 1, 2025. Dr. Stephen Connelly is President of Equillium, Inc. from October 1, 2025. Dr. Connelly is Chief Scientific Officer of Equillium, Inc. from January 01, 2018. Dr. Connelly is a co-founder of Equillium and served as a consultant from March 2017 until January 2018. Dr. Connelly has served as a principal at BioMed Ventures, an investment firm owned by BioMed Realty, LP, since March 2016. From March 2014 to March 2016, Dr. Connelly served as the Director of Business Development and Therapeutic Alliances at aTyr Pharma, Inc., a publicly-held biotechnology company. Prior to that, Dr. Connelly was a Senior Scientist at The Scripps Research Institute from March 2012 to March 2014, where he worked on multiple drug discovery projects spanning different therapeutic areas. Dr. Connelly has broad experience in conducting novel and innovative research and has published over 30 original scientific papers and patents. Dr. Connelly received a B.S. in Medicinal Chemistry and a Ph.D. in Biological Chemistry from the University of Exeter, United Kingdom and an M.B.A. from the Rady School at University of California, San Diego.

Positions